• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见的性激素代谢途径中的遗传变异与子宫内膜癌风险:候选基因的基于途径的评估。

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20852, USA.

出版信息

Carcinogenesis. 2010 May;31(5):827-33. doi: 10.1093/carcin/bgp328. Epub 2010 Jan 6.

DOI:10.1093/carcin/bgp328
PMID:20053928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2864407/
Abstract

BACKGROUND

Estrogen plays a major role in endometrial carcinogenesis, suggesting that common variants of genes in the sex hormone metabolic pathway may be related to endometrial cancer risk. In support of this view, variants in CYP19A1 [cytochrome P450 (CYP), family 19, subfamily A, polypeptide 1] have been associated with both circulating estrogen levels and endometrial cancer risk. Associations with variants in other genes have been suggested, but findings have been inconsistent.

METHODS

We examined 36 sex hormone-related genes using a tagging approach in a population-based case-control study of 417 endometrial cancer cases and 407 controls conducted in Poland. We evaluated common variation in these genes in relation to endometrial cancer risk using sequential haplotype scan, variable-sized sliding window and adaptive rank-truncated product (ARTP) methods.

RESULTS

In our case-control study, the strongest association with endometrial cancer risk was for AR (androgen receptor; ARTP P = 0.006). Multilocus analyses also identified boundaries for a region of interest in AR and in CYP19A1 around a previously identified susceptibility loci. We did not find evidence for consistent associations between previously reported candidate single-nucleotide polymorphisms in this pathway and endometrial cancer risk.

DISCUSSION

In summary, we identified regions in AR and CYP19A1 that are of interest for further evaluation in relation to endometrial cancer risk in future haplotype and subsequent fine mapping studies in larger study populations.

摘要

背景

雌激素在子宫内膜癌的发生中起着重要作用,这表明性激素代谢途径中的基因常见变体可能与子宫内膜癌风险有关。支持这一观点的是,CYP19A1(细胞色素 P450(CYP)家族 19 亚家族 A 多肽 1)中的变体与循环雌激素水平和子宫内膜癌风险都有关。其他基因中的变体也与风险相关,但研究结果并不一致。

方法

我们在波兰进行的一项基于人群的病例对照研究中,使用标记方法研究了 36 个与性激素相关的基因,该研究共纳入了 417 例子宫内膜癌病例和 407 例对照。我们使用连续单体型扫描、可变大小滑动窗口和自适应秩截断乘积(ARTP)方法,评估了这些基因中的常见变异与子宫内膜癌风险的关系。

结果

在我们的病例对照研究中,与子宫内膜癌风险最强相关的是 AR(雄激素受体;ARTP P = 0.006)。多基因分析还确定了 AR 和 CYP19A1 中感兴趣区域的边界,这些区域围绕先前确定的易感基因座。我们没有发现该途径中先前报道的候选单核苷酸多态性与子宫内膜癌风险之间存在一致关联的证据。

讨论

总之,我们确定了 AR 和 CYP19A1 中的区域,这些区域在未来更大的研究人群中进行单体型和随后的精细映射研究时,与子宫内膜癌风险的相关性值得进一步评估。

相似文献

1
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.常见的性激素代谢途径中的遗传变异与子宫内膜癌风险:候选基因的基于途径的评估。
Carcinogenesis. 2010 May;31(5):827-33. doi: 10.1093/carcin/bgp328. Epub 2010 Jan 6.
2
Genetic variation in the androgen receptor gene and endometrial cancer risk.雄激素受体基因的遗传变异与子宫内膜癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):585-9. doi: 10.1158/1055-9965.EPI-08-0677. Epub 2009 Feb 3.
3
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.CYP19A1基因中的两个雌激素相关变异与子宫内膜癌风险:子宫内膜癌联盟流行病学的汇总分析
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689.
4
Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.雌激素生物合成基因变异、性甾体激素水平与子宫内膜癌:一项健康影响评估综述
Am J Epidemiol. 2007 Feb 1;165(3):235-45. doi: 10.1093/aje/kwk015. Epub 2006 Nov 16.
5
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.细胞色素P450 1A1(CYP1A1)、磺基转移酶1A1(SULT1A1)和磺基转移酶1E1(SULT1E1)基因多态性是子宫内膜癌易感性的危险因素。
Cancer. 2008 May 1;112(9):1964-73. doi: 10.1002/cncr.23392.
6
Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.绝经后日本女性中,CYP19A1基因多态性与体重指数在子宫内膜癌风险中的相互作用。
Asian Pac J Cancer Prev. 2011;12(10):2747-52.
7
Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.CYP19A1(芳香化酶)基因多态性与中国女性子宫内膜癌风险
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):943-9. doi: 10.1158/1055-9965.EPI-06-1012.
8
Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.多变量途径关联分析揭示了雌激素代谢遗传决定因素在乳腺癌和子宫内膜癌易感性中的重要性。
PLoS Genet. 2010 Jul 1;6(7):e1001012. doi: 10.1371/journal.pgen.1001012.
9
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.雌激素硫酸化基因、激素替代疗法与子宫内膜癌风险
J Natl Cancer Inst. 2006 Sep 20;98(18):1311-20. doi: 10.1093/jnci/djj360.
10
CYP19 (aromatase) haplotypes and endometrial cancer risk.CYP19(芳香化酶)单倍型与子宫内膜癌风险。
Int J Cancer. 2005 Aug 20;116(2):267-74. doi: 10.1002/ijc.21041.

引用本文的文献

1
Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.胃癌中脂质代谢与免疫浸润特征之间的相关性进展以及将BCHE鉴定为潜在生物标志物
Front Immunol. 2024 Jan 31;15:1327565. doi: 10.3389/fimmu.2024.1327565. eCollection 2024.
2
TransOrGAN: An Artificial Intelligence Mapping of Rat Transcriptomic Profiles between Organs, Ages, and Sexes.TransOrGAN:一种在器官、年龄和性别之间对大鼠转录组图谱进行人工智能映射的方法。
Chem Res Toxicol. 2023 Jun 19;36(6):916-925. doi: 10.1021/acs.chemrestox.3c00037. Epub 2023 May 18.
3
Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer.脂质代谢相关标志物CYP19A1是胃癌预后和免疫细胞浸润的潜在生物标志物。
J Inflamm Res. 2022 Sep 5;15:5075-5088. doi: 10.2147/JIR.S378212. eCollection 2022.
4
Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers.雄激素受体在女性主要生殖系统癌症中的分子调控。
Int J Mol Sci. 2022 Jul 8;23(14):7556. doi: 10.3390/ijms23147556.
5
Endometrial cancer: a genetic point of view.子宫内膜癌:遗传学视角
Transl Cancer Res. 2020 Dec;9(12):7706-7715. doi: 10.21037/tcr-20-2334.
6
Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data.使用 BioPAX-Parser(BiP)为基因或蛋白质列表富集途径数据。
BMC Bioinformatics. 2021 Sep 30;22(Suppl 13):376. doi: 10.1186/s12859-021-04297-z.
7
The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.CYP19A1 变体和单倍型对乳腺癌风险、临床病理特征和预后的影响。
Mol Genet Genomic Med. 2021 Jul;9(7):e1705. doi: 10.1002/mgg3.1705. Epub 2021 May 20.
8
Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.山奈酚,一种天然膳食黄酮类化合物,可抑制17β-雌二醇诱导的生存素表达,并导致子宫内膜癌细胞凋亡。
Oncol Lett. 2018 Nov;16(5):6195-6201. doi: 10.3892/ol.2018.9340. Epub 2018 Aug 21.
9
gene polymorphism and colorectal cancer etiology in Saudi population: case-control study.沙特人群中的基因多态性与结直肠癌病因:病例对照研究
Onco Targets Ther. 2017 Sep 14;10:4559-4567. doi: 10.2147/OTT.S121557. eCollection 2017.
10
Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study.性类固醇激素单核苷酸多态性、农药使用与前列腺癌风险:农业健康研究中的一项巢式病例对照研究
Front Oncol. 2016 Nov 21;6:237. doi: 10.3389/fonc.2016.00237. eCollection 2016.

本文引用的文献

1
Estrogen receptor polymorphisms and the risk of endometrial cancer.雌激素受体多态性与子宫内膜癌风险
BJOG. 2009 Jul;116(8):1053-61. doi: 10.1111/j.1471-0528.2009.02185.x. Epub 2009 May 11.
2
Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.中国人群中孕激素受体基因与子宫内膜癌风险的关联
Cancer. 2009 Jun 15;115(12):2693-700. doi: 10.1002/cncr.24289.
3
Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.UGT1A1和UGT2B7基因变异与子宫内膜癌风险
Pharmacogenet Genomics. 2009 Mar;19(3):239-43. doi: 10.1097/FPC.0b013e328323f66c.
4
Pathway analysis by adaptive combination of P-values.基于 P 值自适应组合的通路分析。
Genet Epidemiol. 2009 Dec;33(8):700-9. doi: 10.1002/gepi.20422.
5
Genetic variation in the androgen receptor gene and endometrial cancer risk.雄激素受体基因的遗传变异与子宫内膜癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):585-9. doi: 10.1158/1055-9965.EPI-08-0677. Epub 2009 Feb 3.
6
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.CYP19A1基因中的两个雌激素相关变异与子宫内膜癌风险:子宫内膜癌联盟流行病学的汇总分析
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689.
7
The Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk.性激素结合球蛋白基因中的天冬氨酸(327)天冬酰胺多态性改变了大豆食品和茶摄入量与子宫内膜癌风险之间的关联。
Nutr Cancer. 2008;60(6):736-43. doi: 10.1080/01635580802192833.
8
Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.雌激素受体α基因多态性与子宫内膜癌风险——一项病例对照研究。
BMC Cancer. 2008 Nov 6;8:322. doi: 10.1186/1471-2407-8-322.
9
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.内源性激素水平与乳腺癌、子宫内膜癌和卵巢癌风险:前瞻性研究
Adv Exp Med Biol. 2008;630:148-65.
10
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).欧洲癌症与营养前瞻性调查(EPIC)中女性内源性性激素与子宫内膜癌风险
Endocr Relat Cancer. 2008 Jun;15(2):485-97. doi: 10.1677/ERC-07-0064.